
To determine the maximum tolerated dose zzso and zzso zzso zzso of zzso after a 72-hour continuous infusion of zzso 

zzso children younger than age 22 years zzso zzso with zzso solid tumors were treated with zzso 45 to 75 zzso infused over the course of 6 hours, followed by a 72-hour continuous infusion of zzso zzso or 1 zzso per day, followed by zzso colony stimulating factor zzso either immediately after treatment or when zzso zzso Patients were zzso by the presence of bone zzso tumor involvement and previous radiation to the bone zzso 

The zzso was zzso zzso zzso count zzso for zzso zzso The zzso was zzso 60 zzso and zzso 1 zzso per day followed by zzso starting 24 hours after chemotherapy for patients without zzso involvement or previous radiation to the bone zzso An acceptable zzso was not found for patients with previous radiation to the bone zzso or bone zzso involvement or without the use of zzso starting 24 hours after chemotherapy was zzso zzso clearance and zzso levels were zzso Limited evidence for zzso activity with this combination was found in zzso 

The recommended dose for phase II trials is zzso 60 zzso followed by a 72-hour infusion of zzso 1 zzso per day with zzso starting 24 hours after the completion of zzso 

